美國生技股

1. More information about the Index can be found at https://indexes.nasdaqomx.com/Index/Overview/NBI
1-YEAR PERFORMANCE QUICK FACTS
Securities:
Currency:
History:
YTD Return:
INDEX TICKERS
Price Return:
Total Return:
Net Total Return:
TOP 10 SECURITIES BY WEIGHT INDUSTRY BREAKDOWN
26.43%
0
REGN
0.00%
VRTX
INCY
MYL
ALXN
ILMN
Technology 0.00%
160
0
0
100.00%
0.00%
INCYTE CORPORATION
MYLAN NV ORD SHS
The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock
Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical companies, and is a modified market
capitalization weighted index.
WEIGHT
0
0
0
0CELG
AMGN
BIIB
GILD
TICKER SECURITIES
0.00%
0
0.00%
SECURITY
CELGENE CORP
AMGEN
3.90%
3.94%
3.79%
BIOGEN INC CMN
GILEAD SCIENCES; INC
REGENERON PHARMACEUT
ALEXION PHARM INC
0
NASDAQ Biotechnology Index
160
USD
11/01/1993
Utilities
NBI
XNBI
N/A
Oil & Gas
Basic Materials
WEIGHT
0.00%
0.00%
ILLUMINA; INC.
VERTEX PHARMACEUTIC
Financials
INDUSTRY
0.00%
0.00%
2.47%
8.40%
8.39%
7.91%
7.74%
6.56%
3.40%
Industrials
Consumer Goods
Health Care
Consumer Services
Telecommunications
-15%
-10%
-5%
0%
5%
10%
15%
20%
9/16 10/16 11/16 12/16 1/17 2/17 3/17 4/17 5/17 6/17 7/17 8/17 9/17
Nasdaq Biotechnology Total Return Index (XNBI) [15.92%]

2. PERFORMANCE(TR Version)
ANNUAL CUMULATIVE ANNUALIZED
ANNUALIZED VOLATILITY(TR Version)
ANNUAL CUMULATIVE
PERFORMANCE(TR Version)
CALENDER YEAR
2008 -12.56%
2011 12.08%
2010 15.25%
2009 15.84%
2014 34.40%
2013 65.97%
2012 32.29%
2017 26.43%
2016 -21.35%
2015 11.77%
15.92%
11.19%
1 Year 15.92%
2 Year -4.09%
1 Year
2 Year
23.58%
61.78%
47.65%
53.72%
5 Year
6 Year
5 Year
6 Year
11.14%
30.91%
19.85%
9 Year 17.54%
26.04%
24.90%
24.26%
3 Year
4 Year
3 Year
4 Year
1 Year
2 Year
3 Year
20.85%
29.89%
27.35%
138.86%
267.18% 24.21%
9 Year 0.60%
10 Year -2.07%
7 Year
15.92%
5.45%
7.31%
12.78%
19.02%
1 Year
2 Year
3 Year
4 Year
5 Year
8 Year
9 Year
10 Year
7 Year 8.55%
8 Year 6.83%
6 Year
298.56%
325.77%
328.31%
319.43%
7 Year
10 Year
21.84%
8 Year
15.42%
7 Year 22.97%
8 Year 21.16%
24.02%
23.68%
1 Year
2 Year
3 Year
4 Year
5 Year
6 Year
20.85%
25.80%
26.32%
4 Year
5 Year
6 Year
25.20%
19.68%
20.73%
10 Year 25.20%
9 Year 36.51%
10 Year 23.15%
7 Year
8 Year
9 Year 25.41%

3. 3-YEAR PERFORMANCE
5-YEAR PERFORMANCE
10-YEAR PERFORMANCE
-10%
0%
10%
20%
30%
40%
50%
9/14
10/14
11/14
12/14
1/15
2/15
3/15
4/15
5/15
6/15
7/15
8/15
9/15
10/15
11/15
12/15
1/16
2/16
3/16
4/16
5/16
6/16
7/16
8/16
9/16
10/16
11/16
12/16
1/17
2/17
3/17
4/17
5/17
6/17
7/17
8/17
9/17
Nasdaq Biotechnology Total Return Index (XNBI) [23.58%]
-20%
0%
20%
40%
60%
80%
100%
120%
140%
160%
180%
200%
Nasdaq Biotechnology Total Return Index (XNBI) [138.86%]
-50%
0%
50%
100%
150%
200%
250%
300%
350%
400%
9/07
12/07
3/08
6/08
9/08
12/08
3/09
6/09
9/09
12/09
3/10
6/10
9/10
12/10
3/11
6/11
9/11
12/11
3/12
6/12
9/12
12/12
3/13
6/13
9/13
12/13
3/14
6/14
9/14
12/14
3/15
6/15
9/15
12/15
3/16
6/16
9/16
12/16
3/17
6/17
9/17
Nasdaq Biotechnology Total Return Index (XNBI) [319.43%]

4. MONTHLY PERFORMANCE(TR Version)
-0.39%
-5.63%
-3.45%
15.67%
-2.99%
2.35%
2.35%
Oct 2008
Sep 2009
Aug 2009
Jul 2009
Jun 2009
May 2009
Apr 2009
May 2008
Apr 2008
-2.13%
2.21%
1.96%
4.41%
6.79%
-9.87%
Mar 2008
Nov 2010
Feb 2010
Jan 2010
5.42%
-11.05%
-0.11%
8.25%
-8.25%
-12.13%
3.87%
-0.30%
8.22%
7.17%
3.70%
-1.20%
Dec 2009
Nov 2009
Oct 2009
-2.51%
-2.37%
1.66%
7.33%
5.84%
1.00%
11.22%
2.03%
4.24%
5.26%
-3.05%
-7.37%
5.56%
-1.58%
Sep 2008
Aug 2008
Jul 2008
Jun 2008
Mar 2009
Feb 2009
Jan 2009
Dec 2008
Nov 2008
Feb 2011
-10.70%
-3.14%
4.15%
7.74%
8.34%
1.63%
3.57%
2.62%
Sep 2011
Aug 2011
Jul 2011
Jun 2011
May 2011
Apr 2011
Mar 2012
Feb 2012
Jan 2012
Dec 2011
Nov 2011
Oct 2011
Mar 2014
Jun 2013
May 2013
Apr 2013
Mar 2013
Apr 2012
2.52%
8.52%
-1.16%
10.31%
-2.34%
Jun 2012
-11.43% May 2012
Mar 2011
7.32%
9.28%
-2.75%
1.93%
4.94%
5.90%
-0.06%
Jul 2014
Jun 2014
Dec 2014
Nov 2014
Oct 2014
Sep 2014
Aug 2014
2.90%
-11.38%
3.07%
-2.93%
12.43%
-10.55%
3.58%
1.17%
Jan 2015
Jul 2015
Jun 2015
May 2015
Apr 2015
Mar 2015
Feb 2015
Jul 2017
Oct 2016
Sep 2016
Aug 2016
Jul 2016
Aug 2015
Oct 2015 7.61%
Sep 2015
Dec 2015 1.25% Aug 2012 1.91%
Nov 2015 2.62% Jul 2012 2.95%
Feb 2016 -4.81% Oct 2012 -7.44%
Jan 2016 -21.01% Sep 2012 4.86%
Apr 2016 2.87% Dec 2012 -1.05%
Mar 2016 2.56% Nov 2012 5.20%
Jun 2016 -7.83% Feb 2013 1.44%
May 2016 4.28% Jan 2013 6.22%
Nov 2016 6.84% Jul 2013 13.94% Mar 2010 6.88%
Dec 2016 -3.15% Aug 2013 -2.04% Apr 2010 0.19%
Jan 2017 4.96% Sep 2013 8.22% May 2010 -10.93%
Feb 2017 6.85% Oct 2013 -2.05% Jun 2010 -4.50%
Mar 2017 -1.17% Nov 2013 9.19% Jul 2010 4.51%
Apr 2017 1.48% Dec 2013 1.27% Aug 2010 -2.83%
May 2017 -3.89% Jan 2014 8.41% Sep 2010 10.28%
Jun 2017 8.56% Feb 2014 7.68% Oct 2010 3.61%
Aug 2017 4.59% Apr 2014 -2.69% Dec 2010 6.93%
Sep 2017 0.11% May 2014 4.26% Jan 2011 0.41%
Feb 2008
Jan 2008
Dec 2007
Nov 2007
Oct 2007
-2.61%
-3.58%
-3.62%
-2.85%
4.39%

5. QUARTERLY PERFORMANCE(TR Version)
Q4 2007 -2.26%
Q1 2008 -6.45%
Q2 2008 1.62%
Q3 2008 5.39%
Q4 2008 -12.72%
Q1 2009 -6.34%
Q2 2009 9.81%
Q3 2009 12.07%
Q4 2009 0.50%
Q1 2010 11.39%
Q2 2010 -14.79%
Q3 2010 11.99%
Q4 2010 8.42%
Q1 2011 7.33%
Q2 2011 6.53%
Q3 2011 -12.45%
Q4 2011 11.96%
Q1 2012 18.21%
Q2 2012 5.59%
Q3 2012 10.01%
Q4 2012 -3.65%
Q1 2013 16.74%
Q2 2013 8.69%
Q3 2013 20.78%
Q4 2013 8.30%
Q1 2014 4.25%
Q2 2014 8.89%
Q3 2014 6.49%
Q4 2014 11.19%
Q1 2015 13.27%
Q2 2015 7.53%
Q3 2015 -17.93%
Q4 2015 11.82%
Q1 2016 -22.88%
Q2 2016 -1.12%
Q3 2016 12.50%
Q3 2017 7.74%
Q4 2016 -8.31%
Q1 2017 10.84%
Q2 2017 5.87%

6. All Information as of 09/29/2017.
Sources: Nasdaq Global Indexes Research. Bloomberg. FactSet.
INDEX DATA SALES
DISCLAIMER
Nasdaq® is a registered trademark of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be
construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy
or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees
of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due
diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
NASDAQ GLOBAL INDEXES NASDAQ LICENSING
1.212.231.5836 1.212.401.8987 1.212.231.1588
© 2017. Nasdaq, Inc. All Rights Reserved.
GLOBALINDEXES@NASDAQ.COM NASDAQLICENSING@NASDAQ.COM GISCUSTOMERSERVICE@NASDAQ.COM
CORPORATE HEADQUARTERS | ONE LIBERTY PLAZA 165 BROADWAY NEW YORK, NY 10006
WORLDWIDE OFFICES | ARMENIA CANADA CHINA DENMARK ESTONIA FINLAND FRANCE GERMANY HONG KONG S.A.R. CHINA
ICELAND INDIA ITALY JAPAN LATVIA LITHUANIA NORWAY NETHERLANDS PHILIPPINES SINGAPORE SPAIN STOCKHOLM
UNITED ARAB EMIRATES UNITED KINGDOM